.svg)
OmicsEdge Partners with Almaden to Streamline Drug Discovery
READ MORE
A new drug discovery service from OmicsEdge using Almaden's g.nome™ makes it easy for labs to quickly analyze a patient’s medical condition and genomics.
BlueHalo and Alpine Partner for Break-Through Innovations in Unmanned Systems
READ MORE
BlueHalo Launches Next Generation of Lighter, Stronger, More Efficient Intense Eye UAS Featuring HX5® Injection Molded Chassis from Alpine Advanced Materials
Almaden Releases g.nome™ with Jupyter Notebook Integration
READ MORE
Almaden Genomics has updated its g.nome™ platform to integrate with Jupyter Notebook, which will further enable scientists to accelerate genomic discovery.
Almaden Genomics Names David Gascoigne as CEO
READ MORE
Gascoigne, a life sciences industry veteran, will drive Almaden as it accelerates genomic research and discovery.
Almaden Genomics Announces Launch of g.nome™ Platform
READ MORE
Almaden Genomics has launched g.nome™, a cloud-native platform designed to streamline genomic workflows and accelerate genomic discovery.
Almaden Genomics Launches Spinoff From IBM Research
READ MORE
Almaden Genomics, a company with roots in an IBM Research laboratory in Silicon Valley, will publicly launch with the introduction of g.nome
Catalyze Dallas Appoints Linda Hart to Board of Advisors
READ MORE
Catalyze Dallas has appointed Linda Hart, vice chairman, president and CEO of the Hart Group, Inc. to its Board of Advisors.
The Power of Resiliency
READ MORE
Faced with seemingly insurmountable challenges, this North Texas innovator refused to give up. Here's how she's helping shape the future.
Tricia D’Cruz Wins Innovative Leader of the Year
READ MORE
Catalyze co-founder and managing director Tricia D'Cruz is recognized as the Innovative Leader of the Year by D CEO and Dallas Innovates.